- Home
- MYGN vs YEXT Comparison
MYGN vs YEXT Comparison
Compare MYGN & YEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- YEXT
- Stock Information
- Founded
- MYGN 1991
- YEXT 2006
- Country
- MYGN United States
- YEXT United States
- Employees
- MYGN N/A
- YEXT N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- YEXT EDP Services
- Sector
- MYGN Health Care
- YEXT Technology
- Exchange
- MYGN Nasdaq
- YEXT Nasdaq
- Market Cap
- MYGN 744.7M
- YEXT 747.5M
- IPO Year
- MYGN 1995
- YEXT 2017
- Fundamental
- Price
- MYGN $4.13
- YEXT $7.03
- Analyst Decision
- MYGN Hold
- YEXT Strong Buy
- Analyst Count
- MYGN 16
- YEXT 3
- Target Price
- MYGN $16.40
- YEXT $9.00
- AVG Volume (30 Days)
- MYGN 3.4M
- YEXT 562.3K
- Earning Date
- MYGN 05-06-2025
- YEXT 06-09-2025
- Dividend Yield
- MYGN N/A
- YEXT N/A
- EPS Growth
- MYGN N/A
- YEXT N/A
- EPS
- MYGN N/A
- YEXT N/A
- Revenue
- MYGN $831,300,000.00
- YEXT $420,957,000.00
- Revenue This Year
- MYGN N/A
- YEXT $8.13
- Revenue Next Year
- MYGN $7.21
- YEXT $5.85
- P/E Ratio
- MYGN N/A
- YEXT N/A
- Revenue Growth
- MYGN 7.38
- YEXT 4.11
- 52 Week Low
- MYGN $3.98
- YEXT $4.29
- 52 Week High
- MYGN $29.30
- YEXT $8.75
- Technical
- Relative Strength Index (RSI)
- MYGN 25.47
- YEXT 71.65
- Support Level
- MYGN $3.81
- YEXT $6.40
- Resistance Level
- MYGN $4.31
- YEXT $6.87
- Average True Range (ATR)
- MYGN 0.47
- YEXT 0.19
- MACD
- MYGN -0.16
- YEXT 0.04
- Stochastic Oscillator
- MYGN 8.00
- YEXT 91.30
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About YEXT Yext Inc.
Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.